Benign Prostatic Hyperplasia Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight

AI Briefing

• – FDA approves new treatment option for BPH
• – Several clinical trials underway to evaluate novel therapies for BPH
• – Researchers explore emerging treatments targeting BPH with innovative mechanisms and delivery methods